1. Home
  2. PMN vs MDRR Comparison

PMN vs MDRR Comparison

Compare PMN & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMN
  • MDRR
  • Stock Information
  • Founded
  • PMN 2004
  • MDRR 2015
  • Country
  • PMN Canada
  • MDRR United States
  • Employees
  • PMN N/A
  • MDRR N/A
  • Industry
  • PMN Pharmaceuticals and Biotechnology
  • MDRR Real Estate Investment Trusts
  • Sector
  • PMN Health Care
  • MDRR Real Estate
  • Exchange
  • PMN Nasdaq
  • MDRR Nasdaq
  • Market Cap
  • PMN 16.0M
  • MDRR 15.6M
  • IPO Year
  • PMN N/A
  • MDRR 2018
  • Fundamental
  • Price
  • PMN $0.99
  • MDRR $10.54
  • Analyst Decision
  • PMN Strong Buy
  • MDRR
  • Analyst Count
  • PMN 3
  • MDRR 0
  • Target Price
  • PMN $4.33
  • MDRR N/A
  • AVG Volume (30 Days)
  • PMN 21.0M
  • MDRR 1.5K
  • Earning Date
  • PMN 08-07-2025
  • MDRR 08-08-2025
  • Dividend Yield
  • PMN N/A
  • MDRR 2.63%
  • EPS Growth
  • PMN N/A
  • MDRR N/A
  • EPS
  • PMN N/A
  • MDRR N/A
  • Revenue
  • PMN N/A
  • MDRR $9,485,128.00
  • Revenue This Year
  • PMN N/A
  • MDRR N/A
  • Revenue Next Year
  • PMN N/A
  • MDRR N/A
  • P/E Ratio
  • PMN N/A
  • MDRR N/A
  • Revenue Growth
  • PMN N/A
  • MDRR N/A
  • 52 Week Low
  • PMN $0.38
  • MDRR $9.55
  • 52 Week High
  • PMN $2.05
  • MDRR $15.00
  • Technical
  • Relative Strength Index (RSI)
  • PMN 67.59
  • MDRR 42.51
  • Support Level
  • PMN $0.77
  • MDRR $10.18
  • Resistance Level
  • PMN $1.59
  • MDRR $11.34
  • Average True Range (ATR)
  • PMN 0.19
  • MDRR 0.12
  • MACD
  • PMN 0.06
  • MDRR -0.04
  • Stochastic Oscillator
  • PMN 50.12
  • MDRR 32.61

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

About MDRR Medalist Diversified REIT Inc.

Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.

Share on Social Networks: